Page last updated: 2024-08-23

isosorbide-5-mononitrate and Angina Pectoris, Variant

isosorbide-5-mononitrate has been researched along with Angina Pectoris, Variant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bansal, M; Kantharia, BK; Makkuni, P; Parameswaran, R1
Distante, A; L'Abbate, A; Lombardi, M; Michelassi, C; Morales, MA; Moscarelli, E1

Trials

1 trial(s) available for isosorbide-5-mononitrate and Angina Pectoris, Variant

ArticleYear
Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study.
    European heart journal, 1993, Volume: 14, Issue:6

    Topics: Administration, Oral; Adult; Angina Pectoris, Variant; Double-Blind Method; Echocardiography; Electrocardiography; Electrocardiography, Ambulatory; Ergonovine; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Vasodilator Agents

1993

Other Studies

1 other study(ies) available for isosorbide-5-mononitrate and Angina Pectoris, Variant

ArticleYear
Why is she fainting?
    The American journal of medicine, 2006, Volume: 119, Issue:8

    Topics: Aged; Angina Pectoris, Variant; Defibrillators, Implantable; Female; Heart Block; Humans; Isosorbide Dinitrate; Nifedipine; Syncope; Tachycardia, Ventricular; Vasodilator Agents

2006